Free Trial

Doximity, Inc. (NASDAQ:DOCS) Receives Average Rating of "Moderate Buy" from Brokerages

Doximity logo with Medical background

Key Points

  • Doximity, Inc. has received an average rating of "Moderate Buy" from 22 brokerages, with an average 1-year target price of $67.42.
  • Recent reports indicate that several analysts have increased their price targets for Doximity, with notable adjustments from Wells Fargo and Needham & Company, raising their targets to $62.00 and $75.00 respectively.
  • Insider trading activity has shown that directors have sold a significant number of shares recently, including a sale of 20,000 shares by Director Timothy S. Cabral, indicating potential changes in insider confidence.
  • Five stocks to consider instead of Doximity.

Shares of Doximity, Inc. (NASDAQ:DOCS - Get Free Report) have earned an average recommendation of "Moderate Buy" from the twenty-two ratings firms that are presently covering the firm, MarketBeat Ratings reports. Eleven equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $67.4211.

Several equities research analysts recently issued reports on the stock. Wells Fargo & Company increased their target price on shares of Doximity from $55.00 to $62.00 and gave the stock an "equal weight" rating in a report on Monday, August 4th. Needham & Company LLC increased their price objective on shares of Doximity from $67.00 to $75.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. KeyCorp raised their price objective on shares of Doximity from $65.00 to $70.00 and gave the company an "overweight" rating in a research report on Monday, July 14th. Evercore ISI raised shares of Doximity from an "in-line" rating to an "outperform" rating and upped their target price for the stock from $50.00 to $70.00 in a report on Wednesday, July 9th. Finally, BTIG Research upgraded Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price target for the company in a research note on Monday, June 2nd.

Check Out Our Latest Stock Analysis on DOCS

Insider Activity at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction on Wednesday, September 24th. The shares were sold at an average price of $75.00, for a total transaction of $1,500,000.00. Following the completion of the transaction, the director directly owned 3,221 shares of the company's stock, valued at approximately $241,575. This trade represents a 86.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction on Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the completion of the sale, the director owned 16,618 shares in the company, valued at approximately $948,721.62. The trade was a 10.74% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 37,000 shares of company stock valued at $2,581,880. 31.30% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Hantz Financial Services Inc. lifted its position in shares of Doximity by 148.9% in the second quarter. Hantz Financial Services Inc. now owns 453 shares of the company's stock worth $28,000 after buying an additional 271 shares in the last quarter. VSM Wealth Advisory LLC bought a new stake in Doximity in the 1st quarter worth approximately $29,000. Allworth Financial LP raised its holdings in shares of Doximity by 104.0% during the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock worth $32,000 after acquiring an additional 287 shares in the last quarter. National Bank of Canada FI bought a new position in shares of Doximity during the 1st quarter valued at approximately $33,000. Finally, Spire Wealth Management grew its holdings in shares of Doximity by 73.2% in the first quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after purchasing an additional 260 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.

Doximity Stock Performance

Shares of Doximity stock opened at $74.46 on Friday. The stock has a market cap of $13.95 billion, a P/E ratio of 74.46, a P/E/G ratio of 4.10 and a beta of 1.37. The stock's fifty day moving average is $66.01 and its 200 day moving average is $60.33. Doximity has a one year low of $40.87 and a one year high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period in the previous year, the business earned $0.28 earnings per share. The business's revenue for the quarter was up 15.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Analysts predict that Doximity will post 0.99 EPS for the current year.

Doximity Company Profile

(Get Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Further Reading

Analyst Recommendations for Doximity (NASDAQ:DOCS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Doximity Right Now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.